Lucy Duarte - International Biotechnology Head Relations

IBT Stock   704.00  4.00  0.57%   

Executive

Lucy Duarte is Head Relations of International Biotechnology Trust
Address 31 Gresham Street, London, United Kingdom, EC2V 7QA
Phone44 20 7421 7070
Webhttps://www.internationalbiotrust.com

International Biotechnology Management Efficiency

The company has return on total asset (ROA) of 0.0806 % which means that it generated a profit of $0.0806 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1407 %, meaning that it generated $0.1407 on every $100 dollars invested by stockholders. International Biotechnology's management efficiency ratios could be used to measure how well International Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, International Biotechnology's Total Current Assets are projected to increase significantly based on the last few years of reporting.

Similar Executives

Showing other executives

EXECUTIVE Age

Didier LeroyToyota Motor Corp
67
Bela KelemenMOL Hungarian Oil
N/A
S KimSamsung Electronics Co
N/A
Sundar RamanReliance Industries Ltd
N/A
Jun NagataToyota Motor Corp
58
Vipul ShahReliance Industries Ltd
N/A
SangKyun KimSamsung Electronics Co
N/A
Pataki SndorOTP Bank Nyrt
N/A
kos SzkelyMOL Hungarian Oil
50
JungSuk KimSamsung Electronics Co
N/A
Nobuhiko MurakamiToyota Motor Corp
65
Laszlo BencsikOTP Bank Nyrt
54
JungSuk KimSamsung Electronics Co
N/A
BE PGDMReliance Industries Ltd
65
James KuffnerToyota Motor Corp
53
Rohit BansalReliance Industries Ltd
N/A
Gabriel SzaboMOL Hungarian Oil
N/A
Parimal NathwaniReliance Industries Ltd
N/A
MSc MBAMOL Hungarian Oil
58
Sanjiv SinghReliance Industries Ltd
64
Robert YiSamsung Electronics Co
N/A
International Biotechnology Trust (IBT) is traded on London Exchange in UK and employs 7 people. International Biotechnology is listed under Asset Management & Custody Banks category by Fama And French industry classification.

Management Performance

International Biotechnology Leadership Team

Elected by the shareholders, the International Biotechnology's board of directors comprises two types of representatives: International Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of International. The board's role is to monitor International Biotechnology's management team and ensure that shareholders' interests are well served. International Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, International Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ailsa Craig, Investment Mang
CEFA MD, Lead Manager
Catherine MBA, Managing Partner
Claire Jackson, Company Secretary
Marek Eng, Investment Mang
Carl Janson, Lead Manager
Lucy Duarte, Head Relations

International Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is International Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in International Stock

International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.